Drug factory · FDA FEI 3003744181
Gentium S.r.L
Piazza XX Settembre, 2, Villa Guardia, Italy
Problems found, fixed voluntarily at FDA's last inspection, Dec 17, 2021.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2015: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Defibrotide Free Acid | Makes the active ingredient and tests it | Jazz Pharmaceuticals, Inc. | 68727-800 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 17, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 15, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 4, 2015 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.